These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 9835501
41. OXA-46, a new class D beta-lactamase of narrow substrate specificity encoded by a blaVIM-1-containing integron from a Pseudomonas aeruginosa clinical isolate. Giuliani F, Docquier JD, Riccio ML, Pagani L, Rossolini GM. Antimicrob Agents Chemother; 2005 May; 49(5):1973-80. PubMed ID: 15855521 [Abstract] [Full Text] [Related]
46. In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015. Karlowsky JA, Kazmierczak KM, Bouchillon SK, de Jonge BLM, Stone GG, Sahm DF. Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670424 [Abstract] [Full Text] [Related]
48. Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. Bert F, Branger C, Lambert-Zechovsky N. J Antimicrob Chemother; 2002 Jul; 50(1):11-8. PubMed ID: 12096001 [Abstract] [Full Text] [Related]
50. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa. Williams RJ, Livermore DM, Lindridge MA, Said AA, Williams JD. J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987 [Abstract] [Full Text] [Related]
54. Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia. Al-Agamy MH, Shibl AM, Tawfik AF, Elkhizzi NA, Livermore DM. J Chemother; 2012 Apr; 24(2):97-100. PubMed ID: 22546765 [Abstract] [Full Text] [Related]
55. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015. Castanheira M, Duncan LR, Mendes RE, Sader HS, Shortridge D. Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263073 [Abstract] [Full Text] [Related]
57. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae. Aktaş Z, Kayacan C, Oncul O. Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508 [Abstract] [Full Text] [Related]
58. Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa. Nordmann P, Ronco E, Naas T, Duport C, Michel-Briand Y, Labia R. Antimicrob Agents Chemother; 1993 May; 37(5):962-9. PubMed ID: 8517722 [Abstract] [Full Text] [Related]
59. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia. Lim KT, Yasin RM, Yeo CC, Puthucheary SD, Balan G, Maning N, Wahab ZA, Ismail N, Tan EA, Mustaffa A, Thong KL. J Microbiol Immunol Infect; 2009 Jun; 42(3):197-209. PubMed ID: 19812853 [Abstract] [Full Text] [Related]
60. Identification of plasmid OXA and other β-lactamase genes among carbapenem-resistant isolates of Pseudomonas aeruginosa from the Clinical University Hospital in northeastern Poland. Sacha P, Michalska A, Ojdana D, Wieczorek P, Hauschild T, Majewski P, Tryniszewska E. New Microbiol; 2015 Apr; 38(2):271-5. PubMed ID: 25938753 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]